Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 988-1001

  Berthier, Celine C ^a   Bethunaickan, Ramalingam ^b   Gonzalez Rivera, Tania ^a   Nair, Viji ^a   Ramanujam, Meera ^b   Zhang, Weijia ^c   Bottinger, Erwin P ^c   Segerer, Stephan ^d   Lindenmeyer, Maja ^d   Cohen, Clemens D ^d   Davidson, Anne ^b   Kretzler, Matthias ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE ACTIVATION; MALE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE REPAIR;

ANIMALS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GLOMERULONEPHRITIS, IGA; HUMANS; INFLAMMATION; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED NZB; NEPHRITIS, INTERSTITIAL; PROTEINURIA; TRANSCRIPTION, GENETIC;

EID: 84863611745     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103031     Document Type: Article

References (62)

1. Doria, A., L. Iaccarino, A. Ghirardello, S. Zampieri, S. Arienti, P. Sarzi-Puttini, F. Atzeni, A. Piccoli, and S. Todesco. 2006. Long-term prognosis and causes of death in systemic lupus erythematosus. Am. J. Med. 119: 700-706. (Pubitemid 44128446)
2. Cook, R. J., D. D. Gladman, D. Pericak, and M. B. Urowitz. 2000. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J. Rheumatol. 27: 1892-1895. (Pubitemid 30670482)
3. Ward, M. M. 2000. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch. Intern. Med. 160: 3136-3140.
4. Ward, M. M. 2009. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004. J. Rheumatol. 36: 63-67.
5. Grande, J. P. 2011. Experimental models of lupus nephritis. Contrib. Nephrol. 169: 183-197.
6. Davidson, A., and C. Aranow. 2010. Lupus nephritis: lessons from murine models. Nat Rev Rheumatol 6: 13-20.
7. Henry, T., and C. Mohan. 2005. Systemic lupus erythematosus-recent clues from congenic strains. Arch. Immunol. Ther. Exp. (Warsz.) 53: 207-212. (Pubitemid 41059741)
8. Lu, Y., R. Rosenfeld, G. J. Nau, and Z. Bar-Joseph. 2010. Cross species expression analysis of innate immune response. J. Comput. Biol. 17: 253-268.
9. Mestas, J., and C. C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738. (Pubitemid 38263654)
10. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
11. Helyer, B. J., and J. B. Howie. 1963. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 197: 197.
12. Singh, R. R., V. Saxena, S. Zang, L. Li, F. D. Finkelman, D. P. Witte, and C. O. Jacob. 2003. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J. Immunol. 170: 4818-4825. (Pubitemid 36519992)
13. Shen, N., Q. Fu, Y. Deng, X. Qian, J. Zhao, K. M. Kaufman, Y. L. Wu, C. Y. Yu, Y. Tang, J. Y. Chen, et al. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107: 15838-15843.
14. Kahn, P., M. Ramanujam, R. Bethunaickan, W. Huang, H. Tao, M. P. Madaio, S. M. Factor, and A. Davidson. 2008. Prevention of murine antiphospholipid syndrome by BAFF blockade. Arthritis Rheum. 58: 2824-2834.
15. Ramanujam, M., and A. Davidson. 2008. Targeting of the immune system in systemic lupus erythematosus. Expert Rev. Mol. Med. 10: e2.
16. Ferenbach, D., and J. Hughes. 2008. Macrophages and dendritic cells: what is the difference? Kidney Int. 74: 5-7. (Pubitemid 351841897)
17. Bethunaickan, R., C. C. Berthier, M. Ramanujam, R. Sahu, W. Zhang, Y. Sun, E. P. Bottinger, L. Ivashkiv, M. Kretzler, and A. Davidson. 2011. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J. Immunol. 186: 4994-5003.
18. Ramanujam, M., R. Bethunaickan, W. Huang, H. Tao, M. P. Madaio, and A. Davidson. 2010. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis Rheum. 62: 1457-1468.
19. Schiffer, L., R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. P. Madaio, E. P. Bottinger, and A. Davidson. 2008. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunol. 180: 1938-1947.
20. Schiffer, L., J. Sinha, X. Wang, W. Huang, G. von Gersdorff, M. Schiffer, M. P. Madaio, and A. Davidson. 2003. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171: 489-497. (Pubitemid 36745324)
21. Schmid, H., A. Boucherot, Y. Yasuda, A. Henger, B. Brunner, F. Eichinger, A. Nitsche, E. Kiss, M. Bleich, H. J. Gröne, et al; European Renal cDNA Bank (ERCB) Consortium. 2006. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003. (Pubitemid 44923635)
22. Cohen, C. D., K. Frach, D. Schlöndorff, and M. Kretzler. 2002. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int. 61: 133-140. (Pubitemid 34075139)
23. Lindenmeyer, M. T., M. Kretzler, A. Boucherot, S. Berra, Y. Yasuda, A. Henger, F. Eichinger, S. Gaiser, H. Schmid, M. P. Rastaldi, et al. 2007. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol. 18: 1765-1776. (Pubitemid 46870313)
24. Berthier, C. C., H. Zhang, M. Schin, A. Henger, R. G. Nelson, B. Yee, A. Boucherot, M. A. Neusser, C. D. Cohen, C. Carter-Su, et al. 2009. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58: 469-477.
25. Johnson, W. E., C. Li, and A. Rabinovic. 2007. Adjusting batch effects in micro-array expression data using empirical Bayes methods. Biostatistics 8: 118-127. (Pubitemid 44906106)
26. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. 2002. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol. 3: H0034.
27. Abruzzo, L. V., L. L. Barron, K. Anderson, R. J. Newman, W. G. Wierda, S. O'Brien, A. Ferrajoli, M. Luthra, S. Talwalkar, R. Luthra, et al. 2007. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology. J. Mol. Diagn. 9: 546-555. (Pubitemid 47434122)
28. Tian, Y., and J. Patel. 2008. TALE: A Tool for Approximate Large Graph Matching. ICDE, IEEE 24th International Conference on Data Engineering. 963-972.
29. Cline, M. S., M. Smoot, E. Cerami, A. Kuchinsky, N. Landys, C. Workman, R. Christmas, I. Avila-Campilo, M. Creech, B. Gross, et al. 2007. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2: 2366-2382.
30. Segerer, S., F. Heller, M. T. Lindenmeyer, H. Schmid, C. D. Cohen, D. Draganovici, J. Mandelbaum, P. J. Nelson, H. J. Gröne, E. F. Gröne, et al. 2008. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 74: 37-46. (Pubitemid 351841902)
31. Saeed, A. I., N. K. Bhagabati, J. C. Braisted, W. Liang, V. Sharov, E. A. Howe, J. Li, M. Thiagarajan, J. A. White, and J. Quackenbush. 2006. TM4 microarray software suite. Methods Enzymol. 411: 134-193.
32. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, et al. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378. (Pubitemid 36184095)
33. Park, M. H., V. D'Agati, G. B. Appel, and C. L. Pirani. 1986. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44: 309-319. (Pubitemid 17178104)
34. Fujii, K., and Y. Kobayashi. 1988. Quantitative analysis of interstitial alterations in lupus nephritis. Virchows Arch. A Pathol. Anat. Histopathol. 414: 45-52. (Pubitemid 19010647)
35. Hill, G. S., M. Delahousse, D. Nochy, E. Thervet, F. Vrtovsnik, P. Rémy, D. Glotz, and J. Bariéty. 2002. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 61: 2176-2186. (Pubitemid 34539335)
36. Hsieh, C., A. Chang, D. Brandt, R. Guttikonda, T. O. Utset, and M. R. Clark. 2011. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) 63: 865-874.
37. Thacker, S. G., C. C. Berthier, D. Mattinzoli, M. P. Rastaldi, M. Kretzler, and M. J. Kaplan. 2010. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J. Immunol. 185: 4457-4469.
38. Duffield, J. S. 2010. Macrophages and immunologic inflammation of the kidney. Semin. Nephrol. 30: 234-254.
39. Duffield, J. S. 2011. Macrophages in kidney repair and regeneration. J. Am. Soc. Nephrol. 22: 199-201.
40. Lee, S., S. Huen, H. Nishio, S. Nishio, H. K. Lee, B. S. Choi, C. Ruhrberg, and L. G. Cantley. 2011. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22: 317-326.
41. Wang, A., A. M. Fairhurst, K. Tus, S. Subramanian, Y. Liu, F. Lin, P. Igarashi, X. J. Zhou, F. Batteux, D. Wong, et al. 2009. CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J. Immunol. 182: 4448-4458.
42. Wang, A., P. Guilpain, B. F. Chong, S. Chouzenoux, L. Guillevin, Y. Du, X. J. Zhou, F. Lin, A. M. Fairhurst, C. Boudreaux, et al. 2010. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum. 62: 3436-3446.
43. Chang, A., S. G. Henderson, D. Brandt, N. Liu, R. Guttikonda, C. Hsieh, N. Kaverina, T. O. Utset, S. M. Meehan, R. J. Quigg, et al. 2011. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol. 186: 1849-1860.
44. Peterson, K. S., J. F. Huang, J. Zhu, V. D'Agati, X. Liu, N. Miller, M. G. Erlander, M. R. Jackson, and R. J. Winchester. 2004. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113: 1722-1733. (Pubitemid 39071664)
45. Soos, T. J., T. N. Sims, L. Barisoni, K. Lin, D. R. Littman, M. L. Dustin, and P. J. Nelson. 2006. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70: 591-596. (Pubitemid 44141588)
46. Krüger, T., D. Benke, F. Eitner, A. Lang, M. Wirtz, E. E. Hamilton-Williams, D. Engel, B. Giese, G. Müller-Newen, J. Floege, and C. Kurts. 2004. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15: 613-621. (Pubitemid 38294791)
47. Suzuki, T., H. Kono, N. Hirose, M. Okada, T. Yamamoto, K. Yamamoto, and Z. Honda. 2000. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. J. Immunol. 165: 473-482. (Pubitemid 30429541)
48. Lindenmeyer, M., E. Noessner, P. J. Nelson, and S. Segerer. 2011. Dendritic cells in experimental renal inflammation-Part I. Nephron Exp. Nephrol. 119: e83-e90.
49. Noessner, E., M. Lindenmeyer, P. J. Nelson, and S. Segerer. 2011. Dendritic cells in human renal inflammation-Part II. Nephron Exp. Nephrol. 119: e91-e98.
50. Xiao, W., H. Hong, Y. Kawakami, C. A. Lowell, and T. Kawakami. 2008. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J. Clin. Invest. 118: 924-934. (Pubitemid 351364600)
51. Totani, L., A. Piccoli, S. Manarini, L. Federico, R. Pecce, N. Martelli, C. Cerletti, P. Piccardoni, C. A. Lowell, S. S. Smyth, et al. 2006. Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. Biochem. J. 396: 89-98. (Pubitemid 43764500)
52. Fitzer-Attas, C. J., M. Lowry, M. T. Crowley, A. J. Finn, F. Meng, A. L. DeFranco, and C. A. Lowell. 2000. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191: 669-682.
53. Chong, B. F., and C. Mohan. 2009. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus. Expert Opin. Ther. Targets 13: 1147-1153.
54. Amanullah, A., D. A. Liebermann, and B. Hoffman. 2002. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation. Oncogene 21: 1600-1610. (Pubitemid 34226148)
55. Van Dang, C., and S. B. McMahon. 2010. Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable? Genes Cancer 1: 560-567.
56. Rigamonti, E., G. Chinetti-Gbaguidi, and B. Staels. 2008. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler. Thromb. Vasc. Biol. 28: 1050-1059.
57. Chawla, A., Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R. M. Evans. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7: 48-52. (Pubitemid 32095641)
58. Majai, G., Z. Sarang, K. Csomós, G. Zahuczky, and L. Fésüs. 2007. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur. J. Immunol. 37: 1343-1354. (Pubitemid 46925318)
59. Aprahamian, T., R. G. Bonegio, C. Richez, K. Yasuda, L. K. Chiang, K. Sato, K. Walsh, and I. R. Rifkin. 2009. The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J. Immunol. 182: 340-346.
60. Zhao, W., S. G. Thacker, J. B. Hodgin, H. Zhang, J. H. Wang, J. L. Park, A. Randolph, E. C. Somers, S. Pennathur, M. Kretzler, et al. 2009. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J. Immunol. 183: 2729-2740.
61. Pahl, M. V., N. D. Vaziri, J. Yuan, and S. G. Adler. 2010. Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 5: 56-61.
62. Psarras, S., M. Mavroidis, D. Sanoudou, C. H. Davos, G. Xanthou, A. E. Varela, V. Panoutsakopoulou, and Y. Capetanaki. 2011. Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur. Heart J. 10.1093/eurheartj/ehr119.